Form 4: Unity Biotechnology CEO Anirvan Ghosh Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Anirvan Ghosh, CEO of Unity Biotechnology, sold 603 shares of common stock at $1.55 per share on May 2, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On May 2, 2024, Anirvan Ghosh, the CEO of Unity Biotechnology, sold 603 shares of the company's common stock.
- The shares were sold at a price of $1.55 per share.
- The sale was executed to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Ghosh beneficially owns 78,143 shares, which includes RSUs that vest over time from the grant date.
Sentiment
Score: 6
Explanation: The document is a routine SEC filing related to stock transactions by a company executive. It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives.
Key Dates
| Date | Description |
|---|---|
| 05/02/2024 | Date of stock sale transaction. |
| 05/03/2024 | Date of signature for the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.